The newly Hemostatic Agents market report provided a complete view of the present and future market. Deep analysis of enterprise competition pattern, enterprise product advantages and disadvantages, regional industrial layout characteristics. The base year considered for the study is 2018 and the market size is projected from 2019 to 2026.
Product Information
Haemostatics are applications designed to stem blood-flow through the accelerated promotion of clotting. Topical hemostatic agents can be divided into three basic categories: fibrin sealants; autologous platelet gel; and commercial derivatives of collagen, gelatin, and cellulose that provide a matrix for endogenous coagulation.
On the basis of products, the various types include Thrombin, Oxidized Regenerated Cellulose, Combination, Gelatin, Collagen, and Other. On the basis of application, the Hemostatic Agents market is segmented into Hospitals, Surgical Centers, and Nursing Homes.
Get FREE Sample of Hemostatic Agents Market Report at:
Market Insights
According to a new research study, the Hemostatic Agents market size is expected to reach USD 8,720 million by 2026 from USD 5,360 million in 2019, with a compound annual growth rate of 7.20% during the forecast period. The growth can be mainly attributed to an increase in demand across the world for minimally invasive surgeries along with the continual rise in geriatric patients with chronic conditions. Moreover, a growing emphasis on effective measures for blood loss management during surgeries and the significant rate of growth in the number of hospitals and surgical centers in markets of emerging economies are expected to promote the growth of the market.
Regional Segment Analysis
The report focuses on detailed analysis of major regions like North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia), and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
North America is the largest market with a share of 32.15%, followed by Asia-Pacific and Europe, accounting for 27.25% and 27.20% respectively. North America is anticipated to remain dominant in the forthcoming years, owing to the growing prevalence of cardiovascular disorders within the region. Asia-Pacific is projected to show significant growth in the coming years, owing to rapidly improving healthcare infrastructure, rising medical tourism, and the growing aging population in countries such as China and India.
Purchase a copy of Hemostatic Agents report at:
Competitive Players
The Hemostatic Agents market is full of competition due to the presence of many large and small companies and local manufacturers. The leading vendors in the market are Baxter International Incorporation, C.R. Bard Incorporation, B.Braun Melsungen AG, Integra Life Sciences Corporation, and Equimedical. Other prominent vendors in the market are Marine Polymer Technologies, Gelita GmbH, Johnson and Johnson Services Inc, Pfizer Inc, Advanced Medical Solutions Group, Vascular Solutions, Inc, Z-Medica LLC, Mallinckrodt Plc, Covidien PLC., Atrium Medical Corporation, Sanofi Group, Cryolife, Inc., Hemostasis, LLC, and others.
Target Audience for this Report
l Hemostatic Agents manufacturers
l Hemostatic Agents importers and exporters
l Hemostatic Agents traders, distributors, and suppliers
l Raw material suppliers of Hemostatic Agents
l Hemostatic Agents industry associations
l Product managers, Hemostatic Agents industry administrator, C-level executives of the industries
l Market Research and consulting firms
l Healthcare organizations
l Research & Clinical Laboratories
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hemostatic Agents Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Hemostatic Agents Market by Types
4 Segmentation of Hemostatic Agents Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Hemostatic Agents Market in Major Countries
7 North America Hemostatic Agents Landscape Analysis
8 Europe Hemostatic Agents Landscape Analysis
9 Asia Pacific Hemostatic Agents Landscape Analysis
10 Latin America, Middle East & Africa Hemostatic Agents Landscape Analysis
11 Major Players Profile
11.1 Baxter International Incorporation
11.1.1 Baxter International Incorporation Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 C.R. Bard Incorporation
11.3 B.Braun Melsungen AG
11.4 Integra Life Sciences Corporation
11.5 Equimedical
11.6 Marine Polymer Technologies
11.7 Gelita GmbH
11.8 Johnson and Johnson Services Inc
11.9 Pfizer Inc
11.10 Advanced Medical Solutions Group
11.11 Vascular Solutions, Inc
11.12 Z-Medica LLC
11.13 Mallinckrodt Plc
11.14 Covidien PLC.
11.15 Atrium Medical Corporation
11.16 Sanofi Group
11.17 Cryolife, Inc.
11.18 Hemostasis, LLC
…
Ask for a discount at:
Key questions answered in the report
l What will the market size and growth rate be in 2026?
l What segment or region will drive or lead the market growth and what are the reasons?
l How will market drivers, constraints and future opportunities affect market dynamics and subsequent analysis of relevant trends?
l What key strategies are used by top vendors to increase revenue?
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese